Orgenesis Q2 EPS $(0.15) Up From $(0.22) YoY, Sales $6.97M Down From $7.20M YoY
Portfolio Pulse from Benzinga Newsdesk
Orgenesis (NASDAQ:ORGS) reported Q2 losses of $(0.15) per share, a 31.82% improvement from $(0.22) per share YoY. However, sales decreased by 3.14% to $6.97M from $7.20M YoY.
August 11, 2023 | 11:10 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Orgenesis reported improved Q2 EPS but lower sales YoY. This mixed result could lead to uncertain market reactions.
While the improved EPS indicates better profitability, the decrease in sales could be a concern for investors. The mixed results may lead to a neutral or uncertain market reaction in the short term.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100